BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 26381879)

  • 21. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation.
    Naftali T; Novick D; Gabay G; Rubinstein M; Novis B
    Isr Med Assoc J; 2007 Jul; 9(7):504-8. PubMed ID: 17710779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up Study.
    van Erp SJ; Brakenhoff LK; van Gaalen FA; van den Berg R; Fidder HH; Verspaget HW; Huizinga TW; Veenendaal RA; Wolterbeek R; van der Heijde D; van der Meulen-de Jong AE; Hommes DW
    J Crohns Colitis; 2016 Feb; 10(2):166-75. PubMed ID: 26512134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease.
    Algaba A; Linares PM; Fernández-Contreras ME; Ordoñez A; Trápaga J; Guerra I; Chaparro M; de la Poza G; Gisbert JP; Bermejo F
    J Crohns Colitis; 2013 Dec; 7(11):e569-79. PubMed ID: 23642997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular complications in inflammatory bowel disease.
    Schicho R; Marsche G; Storr M
    Curr Drug Targets; 2015; 16(3):181-8. PubMed ID: 25642719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of chronic pain in osteoarthritis on the risk of cardiovascular diseases and modern methods of drug prevention].
    Sarvilina IV; Danilov AB; Tkacheva ON; Gromova OA; Solovieva EY; Dudinskaya EN; Rozanov AV; Kartashova EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(5):20-30. PubMed ID: 37315238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Chondroitin Sulphate on Pro-Inflammatory Mediators and Disease Activity in Patients with Inflammatory Bowel Disease.
    Linares PM; Chaparro M; Algaba A; Román M; Moreno Arza I; Abad Santos F; Ochoa D; Guerra I; Bermejo F; Gisbert JP
    Digestion; 2015; 92(4):203-10. PubMed ID: 26381879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of experimental accelerated atherosclerosis by chondroitin sulphate.
    Martínez-Calatrava MJ; Largo R; Herrero-Beaumont G
    Osteoarthritis Cartilage; 2010 Jun; 18 Suppl 1():S12-6. PubMed ID: 20399896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems.
    Lauder RM
    Complement Ther Med; 2009 Jan; 17(1):56-62. PubMed ID: 19114230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule.
    Volpi N
    Inflammopharmacology; 2011 Dec; 19(6):299-306. PubMed ID: 22042237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets.
    Gravina AG; Dallio M; Masarone M; Rosato V; Aglitti A; Persico M; Loguercio C; Federico A
    Oxid Med Cell Longev; 2018; 2018():2568569. PubMed ID: 29849875
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.